Inventor · disambiguated record
John David Lawson
Also filed as: LAWSON JOHN D · LAWSON JOHN DAVID
24 granted patents·22 pending applications·59 citations·filing 2009–2025
93Inventor score
Files withMIRATI THERAPEUTICS INC29TAKEDA PHARMACEUTICALS CO8CHEN YOUNG K2TAKEDA PHARMACEUTICAL2BRESSI JEROME C1
Top patents by PatentIndex Score
46 records- 0196US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0293US9434743B2Indazole derivativesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 6, 2016·20 cites·18 claims
- 0392US12421253B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·1 cites·29 claims
- 0492US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0591US10647715B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted May 12, 2020·10 cites·9 claims
- 0689US11999753B2Tetrahydropyridopyrimidine pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·1 cites·5 claims
- 0784US11479551B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Oct 25, 2022·1 cites·30 claims
- 0879US9402841B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Aug 2, 2016·1 cites·36 claims
- 0977US12304915B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·81 claims
- 1077US9073918B2Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5KWOK LILY·Filed 2011·Granted Jul 7, 2015·6 cites·13 claims
- 1177US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1276US9827255B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 28, 2017·1 cites·37 claims
- 1375US9801872B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 31, 2017·1 cites·33 claims
- 1475US2025270220A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1572US2023054883A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1671US2019224190A1Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 1770US2025388606A1Azaquinazoline pan-kras inhibitorsMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1868US12398154B2Azaquinazoline pan-KRas inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Aug 26, 2025·0 cites·49 claims
- 1968US11492351B2MTA-cooperative PRMT5 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Nov 8, 2022·0 cites·27 claims
- 2068US2020262837A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2167US11702418B2SOS1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jul 18, 2023·0 cites·72 claims
- 2267US10307414B2Pyridinyl and fused pyridinyl triazolone derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 4, 2019·0 cites·11 claims
- 2367US9365566B2Cinnoline derivativesTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jun 14, 2016·1 cites·16 claims
- 2467US2024391882A1Substituted QuinoxalinesMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2566US8071766B2HSP90 inhibitorsCHEN YOUNG K·Filed 2009·Granted Dec 6, 2011·1 cites·10 claims
- 2666US2025382290A1Salts of sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2764US2025368649A1Tetrahydropyridopyrimidine pan-kras inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2864US2024025907A1QUINAZOLINE PAN-KRas INHIBITORSMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2960US10328089B2Fumagillol derivativesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 25, 2019·0 cites·35 claims
- 3059US2024228510A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3159US2024368153A1Aminopyridine-based MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3259US2025059182A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3359US2020308170A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3457US2024208912A1MTA-Cooperative PRMT5 InhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3557US2024034733A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3656US8618290B2HSP90 inhibitorsLAWSON JOHN D·Filed 2011·Granted Dec 31, 2013·0 cites·6 claims
- 3755US2023312482A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3854US2023101312A1Sos1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3954US2023339976A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4053US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4152US8785429B2Dihydropyrrolonaphthyridinone compounds as inhibitors of JAKTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jul 22, 2014·0 cites·17 claims
- 4252US2011136766A1Aurora kinase inhibitorsVITAE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4346US8420816B2Dihydropyrrolonaphthyridinone compounds as inhibitors of JAKDONG QING·Filed 2010·Granted Apr 16, 2013·0 cites·15 claims
- 4444US2012172321A1Hsp90 inhibitorsCHEN YOUNG K·Filed 2012·Application pending·0 cites
- 4543US9475816B2Substituted-1,4-dihydropyrazolo[4,3-b]indolesTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 25, 2016·0 cites·17 claims
- 4643US8178534B2cMET inhibitorsBRESSI JEROME C·Filed 2009·Granted May 15, 2012·0 cites·53 claims
Join the waitlist — get patent alerts
Get an alert when John David Lawson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →